165 related articles for article (PubMed ID: 25213993)
21. The impact of chemokine receptor CXCR4 on breast cancer prognosis: a meta-analysis.
Xu TP; Shen H; Liu LX; Shu YQ
Cancer Epidemiol; 2013 Oct; 37(5):725-31. PubMed ID: 23763828
[TBL] [Abstract][Full Text] [Related]
22. CD133+ and Nestin+ Glioma Stem-Like Cells Reside Around CD31+ Arterioles in Niches that Express SDF-1α, CXCR4, Osteopontin and Cathepsin K.
Hira VV; Ploegmakers KJ; Grevers F; Verbovšek U; Silvestre-Roig C; Aronica E; Tigchelaar W; Turnšek TL; Molenaar RJ; Van Noorden CJ
J Histochem Cytochem; 2015 Jul; 63(7):481-93. PubMed ID: 25809793
[TBL] [Abstract][Full Text] [Related]
23. The role of CXCR4 in highly malignant human gliomas biology: current knowledge and future directions.
Gagliardi F; Narayanan A; Reni M; Franzin A; Mazza E; Boari N; Bailo M; Zordan P; Mortini P
Glia; 2014 Jul; 62(7):1015-23. PubMed ID: 24715652
[TBL] [Abstract][Full Text] [Related]
24. The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.
Garside R; Pitt M; Anderson R; Rogers G; Dyer M; Mealing S; Somerville M; Price A; Stein K
Health Technol Assess; 2007 Nov; 11(45):iii-iv, ix-221. PubMed ID: 17999840
[TBL] [Abstract][Full Text] [Related]
25. Clinicopathological and prognostic significance of chemokine receptor CXCR4 overexpression in patients with esophageal cancer: a meta-analysis.
Wu J; Wu X; Liang W; Chen C; Zheng L; An H
Tumour Biol; 2014 Apr; 35(4):3709-15. PubMed ID: 24326770
[TBL] [Abstract][Full Text] [Related]
26. Prognosis and Clinicopathology of CXCR4 in Colorectal Cancer Patients: a Meta-analysis.
Li LN; Jiang KT; Tan P; Wang AH; Kong QY; Wang CY; Lu HR; Wang J
Asian Pac J Cancer Prev; 2015; 16(9):4077-80. PubMed ID: 25987090
[TBL] [Abstract][Full Text] [Related]
27. Prognostic Value of High CXCR4 Expression in Renal Cell Carcinoma: A System Review and Meta-Analysis.
Du Y; Long Q; Guan B; Mu L
Dis Markers; 2015; 2015():568980. PubMed ID: 26526157
[TBL] [Abstract][Full Text] [Related]
28. Overexpression of chemokine receptor CXCR4 predicts lymph node metastatic risk in patients with melanoma: A systematic review and meta-analysis.
Alimohammadi M; Rahimi A; Faramarzi F; Alizadeh-Navaei R; Rafiei A
Cytokine; 2021 Dec; 148():155691. PubMed ID: 34464923
[TBL] [Abstract][Full Text] [Related]
29. Prognostic role of microRNA-155 expression in gliomas: A meta-analysis.
Zhou Y; Wang X; Liu Z; Huang X; Li X; Cheng K; Jiang X
Clin Neurol Neurosurg; 2019 Jan; 176():103-109. PubMed ID: 30554090
[TBL] [Abstract][Full Text] [Related]
30. A meta-analysis for CXCR4 as a prognostic marker and potential drug target in non-small cell lung cancer.
Zhang C; Li J; Han Y; Jiang J
Drug Des Devel Ther; 2015; 9():3267-78. PubMed ID: 26150700
[TBL] [Abstract][Full Text] [Related]
31. Prognostic Role of MicroRNA 222 in Patients with Glioma: A Meta-analysis.
Song Y; Zhang J; He M; Xu J
Biomed Res Int; 2020; 2020():4689689. PubMed ID: 33029509
[TBL] [Abstract][Full Text] [Related]
32. Prognostic role of microvessel density in patients with glioma.
Fan C; Zhang J; Liu Z; He M; Kang T; Du T; Song Y; Fan Y; Xu J
Medicine (Baltimore); 2019 Mar; 98(9):e14695. PubMed ID: 30817605
[TBL] [Abstract][Full Text] [Related]
33. Expression of the new CXCL12 receptor, CXCR7, in gliomas.
Calatozzolo C; Canazza A; Pollo B; Di Pierro E; Ciusani E; Maderna E; Salce E; Sponza V; Frigerio S; Di Meco F; Schinelli S; Salmaggi A
Cancer Biol Ther; 2011 Jan; 11(2):242-53. PubMed ID: 21084856
[TBL] [Abstract][Full Text] [Related]
34. Relaxation-compensated amide proton transfer (APT) MRI signal intensity is associated with survival and progression in high-grade glioma patients.
Paech D; Dreher C; Regnery S; Meissner JE; Goerke S; Windschuh J; Oberhollenzer J; Schultheiss M; Deike-Hofmann K; Bickelhaupt S; Radbruch A; Zaiss M; Unterberg A; Wick W; Bendszus M; Bachert P; Ladd ME; Schlemmer HP
Eur Radiol; 2019 Sep; 29(9):4957-4967. PubMed ID: 30809720
[TBL] [Abstract][Full Text] [Related]
35. HGF upregulates CXCR4 expression in gliomas via NF-kappaB: implications for glioma cell migration.
Esencay M; Newcomb EW; Zagzag D
J Neurooncol; 2010 Aug; 99(1):33-40. PubMed ID: 20157762
[TBL] [Abstract][Full Text] [Related]
36. ACTC1 as an invasion and prognosis marker in glioma.
Ohtaki S; Wanibuchi M; Kataoka-Sasaki Y; Sasaki M; Oka S; Noshiro S; Akiyama Y; Mikami T; Mikuni N; Kocsis JD; Honmou O
J Neurosurg; 2017 Feb; 126(2):467-475. PubMed ID: 27081897
[TBL] [Abstract][Full Text] [Related]
37. High bone sialoprotein (BSP) expression correlates with increased tumor grade and predicts a poorer prognosis of high-grade glioma patients.
Xu T; Qin R; Zhou J; Yan Y; Lu Y; Zhang X; Fu D; Lv Z; Li W; Xia C; Hu G; Ding X; Chen J
PLoS One; 2012; 7(10):e48415. PubMed ID: 23119009
[TBL] [Abstract][Full Text] [Related]
38. CXCR4--A Prognostic and Clinicopathological Biomarker for Pancreatic Ductal Adenocarcinoma: A Meta-Analysis.
Krieg A; Riemer JC; Telan LA; Gabbert HE; Knoefel WT
PLoS One; 2015; 10(6):e0130192. PubMed ID: 26091099
[TBL] [Abstract][Full Text] [Related]
39. Association of osteopontin expression with the prognosis of glioma patient: a meta-analysis.
Zhao M; Xu H; Liang F; He J; Zhang J
Tumour Biol; 2015 Jan; 36(1):429-36. PubMed ID: 25266800
[TBL] [Abstract][Full Text] [Related]
40. Proliferating Cell Nuclear Antigen Has an Association with Prognosis and Risks Factors of Cancer Patients: a Systematic Review.
Lv Q; Zhang J; Yi Y; Huang Y; Wang Y; Wang Y; Zhang W
Mol Neurobiol; 2016 Nov; 53(9):6209-6217. PubMed ID: 26558632
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
